Nuwellis terminated its REVERSE‑HF randomized trial comparing ultrafiltration with IV loop diuretics in hospitalized heart ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...

Heart Failure on the other hand develops because the heart is unable ... of the heart and blood tests like NT pro BNP blood ...

A 74-year-old woman develops haemolytic anaemia and stress cardiomyopathy after a tick bite, highlighting a rare cardiac complication of babesiosis.

The drug is now approved for treating people with an LVEF of at least 40%, with or without chronic kidney disease.

The FDA has approved Kerendia® (finerenone) to reduce the risk of cardiovascular death, hospitalization for HF, and urgent HF visits.

Finerenone gained FDA approval for heart failure treatment, showcasing significant benefits in reducing cardiovascular events ...

The study revealed that people with these genetic changes were found to be more than twice as likely to develop heart failure ...

Jardiance is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. Here’s how it treats heart failure.

One of the earliest signs of heart failure is feeling unusually tired or weak, even during simple daily activities like climbing stairs, shopping, or ...